Cancer cell line screening: a compass for drug discovery
Large-panel cancer cell line screening can help find the right fit between a specific cancer…
Large-panel cancer cell line screening can help find the right fit between a specific cancer…
Labiotech recently interviewed Nathan Buchbinder, chief product officer at Proscia, about digital pathology. AI has…
A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness…
By Sheelagh Frame, CSO at Ubiquigent Modulation of the ubiquitin-proteasome system (UPS) presents a rich…
The IRBM Group is an innovative research and discovery CRO (contract research organization) working across…
Over the years, CROs have evolved from a transactional ‘pair of hands’ to organizations that…
Cyclica Inc. and SK Chemicals Co., Ltd. have announced an AI-driven drug discovery and development…
PrecisionLife Limited has entered into a multi-target discovery and validation partnership with Ono Pharmaceutical Co.,…
PhoreMost Ltd. and ThinkCyte K.K have announced a strategic research partnership aimed at advancing modern…
Discovering new drugs remains an inefficient, trial and error-based process. The founding team behind the…
Vevo Therapeutics, a biotechnology company using its Mosaic in vivo drug discovery platform and next…
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…